These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1675482)

  • 1. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
    Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
    Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle.
    Mattern T; Ansorge S; Flad HD; Ulmer AJ
    Immunobiology; 1993 Jun; 188(1-2):36-50. PubMed ID: 8104880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.
    Ulmer AJ; Mattern T; Feller AC; Heymann E; Flad HD
    Scand J Immunol; 1990 Apr; 31(4):429-35. PubMed ID: 1970666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
    Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
    Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients.
    Uematsu T; Urade M; Yamaoka M
    J Oral Pathol Med; 1998 Mar; 27(3):106-10. PubMed ID: 9563801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation.
    Bednarczyk JL; Carroll SM; Marin C; McIntyre BW
    J Cell Biochem; 1991 Jul; 46(3):206-18. PubMed ID: 1723066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus Cowan I and pokeweed mitogen.
    Gruber M; Scholz W; Flad HD
    Cell Immunol; 1988 May; 113(2):423-34. PubMed ID: 2896071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster.
    de Meester I; Scharpé S; Vanham G; Bosmans E; Heyligen H; Vanhoof G; Corte G
    Immunobiology; 1993 Jun; 188(1-2):145-58. PubMed ID: 8104877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
    Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
    Vanham G; Kestens L; De Meester I; Vingerhoets J; Penne G; Vanhoof G; Scharpé S; Heyligen H; Bosmans E; Ceuppens JL
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):749-57. PubMed ID: 8099610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
    Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
    Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies.
    Torimoto Y; Dang NH; Tanaka T; Prado C; Schlossman SF; Morimoto C
    Mol Immunol; 1992 Feb; 29(2):183-92. PubMed ID: 1371820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status.
    Ruiz P; Hao L; Zucker K; Zacharievich N; Viciana AL; Shenkin M; Miller J
    Transpl Immunol; 1997 Jun; 5(2):152-61. PubMed ID: 9269038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the T cell activation monoclonal antibody Ta1 to dipeptidyl peptidase IV.
    Barton RW; Prendergast J; Kennedy CA
    J Leukoc Biol; 1990 Oct; 48(4):291-6. PubMed ID: 1975616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.
    Tanaka T; Duke-Cohan JS; Kameoka J; Yaron A; Lee I; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3082-6. PubMed ID: 7909158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the target of monoclonal antibody A6H as dipeptidyl peptidase IV/CD26 by LC MS\MS.
    Hass GM; Meyer JL; Newitt RA; Labuda T; Brown L; Aebersold R; Vessella RL
    Hybridoma; 2001 Aug; 20(4):231-6. PubMed ID: 11604108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD26 (dipeptidyl peptidase IV) on memory and naive T lymphocytes.
    Ulmer AJ; Mattern T; Flad HD
    Scand J Immunol; 1992 May; 35(5):551-9. PubMed ID: 1374571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production.
    Reinhold D; Bank U; Bühling F; Neubert K; Mattern T; Ulmer AJ; Flad HD; Ansorge S
    Immunobiology; 1993 Aug; 188(4-5):403-14. PubMed ID: 7902330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.